Newcastle University spinout Jetbio is introducing 3D bioprinting products in the global multi-billion-dollar 3D bioprinting market for drug discovery, tissue engineering and regenerative medicine. Jetbio 3D bioprinting systems will rapidly print and deliver more accurate 3D printed models that closely mimic human tissue for the pre-clinical testing of new drug components.
The Jetbio technology will support applications in tissue engineering, for example in-clinic processing of 3D tissue constructs for regenerative implants.
The Jetbio Reactive Jet Impingement (ReJI) patents are granted in the USA and Europe.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Stephenson Building, Newcastle,united Kingdom
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.jet-bio.com
- Keywords
- drug discovery, 3D bioprinting, bio-inkjet technology, tissue models, regenerative medicine, manufacturing engineering, business development, collaborative research, biomaterials, tissue engineering, bioinkjet systems development.
- HQ
- Newcastle
Jetbio Ltd Questions
Jetbio Ltd's website is http://www.jet-bio.com
Jetbio Ltd's LinkedIn profile is https://uk.linkedin.com/company/jetbio-ltd
Jetbio Ltd has
1 employees.
View email and phone details for 1
employees at Jetbio Ltd.
Jetbio Ltd's industry is
Pharmaceutical Manufacturing
Jetbio Ltd's top competitors are
Aten,
White-Tillet,
Lemki Robotix Llc,
Fileclo,
Simed Global,
Earswitch,
Sundara Pharma,
Renewvax Ltd,
Turbinia Ltd,
Labman.
Jetbio Ltd's categories are Pharmaceutical Manufacturing
Jetbio Ltd's founding year is 2023
